|
Originally published In Press as doi:10.1074/jbc.M412688200 on March 2, 2005
J. Biol. Chem., Vol. 280, Issue 20, 19695-19703, May 20, 2005
Novel Binding Epitope for Helicobacter pylori Found in Neolacto Carbohydrate Chains
STRUCTURE AND CROSS-BINDING PROPERTIES*
Halina Miller-Podraza ,
Boel Lanne ¶,
Jonas Ångström ,
Susann Teneberg,
Maan Abul Milh,
Per-Åke Jovall,
Hasse Karlsson, and
Karl-Anders Karlsson
From the
Institute of Medical Biochemistry, Göteborg University, P. O. Box 440, SE 40530 Göteborg, Sweden
Helicobacter pylori is a bacterium that colonizes the stomach of a majority of the global human population causing common gastric diseases like ulcers and cancer. It has an unusually complex pattern of binding to various host glycoconjugates including interaction with sialylated, sulfated, and fucosylated sequences. The present study describes an additional binding epitope comprising the neolacto internal sequence of GlcNAc 3-Gal 4GlcNAc . The binding was detected on TLC plates as an interaction with a seven-sugar ganglioside of rabbit thymus. The glycolipid was purified and characterized as Neu5Gc 3Gal 4GlcNAc 3Gal 4GlcNAc 3-Gal 4Glc 1Cer with less than 10% of the fraction carrying a repeated lacto (type-1) core chain, Gal 3Glc-NAc 3Gal 3GlcNAc . After stepwise chemical and enzymatic degradation and structural analysis of products the strongest binder was found to be the pentaglycosylceramide GlcNAc 3Gal 4GlcNAc 3Gal 4Glc 1-Cer, whereas the hexa- and tetraglycosylceramides were less active, and the trihexosylceramide was inactive. Further studies revealed that the terminal GlcNAc of the pentaglycosylceramide may be exchanged for either GalNAc 3, GalNAc 3, or Gal 3 without loss of the activity. Calculated minimum energy conformers of these four isoreceptors show a substantial topographical similarity suggesting that this binding is a result of a molecular mimicry. Although the glycoconjugate composition of human gastric epithelial cells is not known in detail it is proposed that repeating N-acetyllactosamine units of glycoconjugates may serve as bacterial attachment sites in the stomach.
Received for publication, November 9, 2004
, and in revised form, March 2, 2005.
* This work was supported by Swedish Research Council Grant 06X-12628, the Swedish Cancer Foundation, Wilhelm and Martina Lundgrens Research Foundation, the Swedish Medical Society, the Adlerbertska Research Foundation, Ingabritt and Arne Lundberg Foundation, and Symbicom Ltd. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
These authors contributed equally to this work.
¶ Present address: AstraZeneca R&D, S-431 83 Mölndal, Sweden.
To whom correspondence should be addressed. Tel.: 46-31-773-3154; Fax: 46-31-416108; Email: Halina.Miller-Podraza{at}medkem.gu.se.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Kobayashi, H. Lee, J. Nakayama, and M. Fukuda
Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection
Glycobiology,
May 1, 2009;
19(5):
453 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Miller-Podraza, K. Weikkolainen, T. Larsson, P. Linde, J. Helin, J. Natunen, and K.-A. Karlsson
Helicobacter pylori binding to new glycans based on N-acetyllactosamine
Glycobiology,
April 1, 2009;
19(4):
399 - 407.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|